Publication | Closed Access

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908

Breast OncologyOncologyCancer ManagementBreast CancerTrial 9908Preoperative Weekly CisplatinCancer TreatmentMedicineRadiation Oncology